Written and edited by leading cancer experts at Memorial Sloan Kettering Cancer Center, Pocket Oncology, Second Edition , is a practical, high-yield reference for trainees and practitioners of medical oncology and hematology. This easy-to-use, loose-leaf resource contains up-to-date information essential to caring for patients with cancer, from cancer biology, prevention, screening, treatment and supportive care to new advances in immuno-oncology and precision medicine.
Includes new information on chimeric antigen receptor (CAR) T cell therapy, immunotherapy toxicity, and novel oral anticoagulants, as well as more information on precision targeted therapeutic strategies. Presents each oncologic disease on two facing pages that review initial clinical presentation, pathophysiology, staging, current standards of care treatments, and active areas of current research. Follows the popular Pockets Notebook format, featuring bulleted lists, tables, diagrams, and algorithms that make essential facts easy to find and retain. Contains helpful appendices on radiographic response criteria, quality of life assessments, tumor markers, and more, plus a section of clinically essential color photos. Ideal as a pocket reference for daily practice as well as an accepted and trusted resource for trainees and other members of the oncology care team.
9781496391063
= activity adenoca adjuvant Adverse effects agents anemia blood bone Bortezomib breast Cancer Cancer Center NewYork carboplatin carcinoma cell chemo chemotherapy chromosome cisplatin Clin Oncol Clinical pearls clinical trial common conc cyclophosphamide cytarabine cytopenias Department of Medicine dexamethasone disease docetaxel dose adjustments recommended Dosing/dose adjustments doxorubicin drug emetogenic Epidemiology etoposide evaluation factors gene Genetics grade h Adverse hepatic hepatic dose adjustments hepatic metabolism hormone ifosfamide imatinib infxn inhibitors invasion irinotecan lenalidomide lesions leukemia liver lung lymphocytes lymphoma malignancies Median Medicine Memorial Sloan-kettering melanoma Memorial Sloan-kettering Cancer Myelosuppression NEJM neutropenia oncology ovarian paclitaxel peripheral PK/PD PKIPD prognosis prostate protein radiation receptor recurrence regimens renal resection risk rituximab sarcoma serum skin Sloan-kettering Cancer Center Sorafenib Stage subtype surgery surgical syndrome therapy tissue tumor w/in warfarin
-- Medical / Oncology / General--Medical › Oncology › General --Neoplasms